DALACINE

This brand name is authorized in France, Tunisia

Active ingredients

The drug DALACINE contains one active pharmaceutical ingredient (API):

1 Clindamycin
UNII ZNC153389R - CLINDAMYCIN HYDROCHLORIDE MONOHYDRATE

Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis.

Read about Clindamycin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J01FF01 Clindamycin J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FF Lincosamides
Discover more medicines within J01FF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: FR Base de donnรฉes publique des mรฉdicaments Identifier(s): 60909099, 60978355, 62286010, 64596029, 64829519, 69913330
Country: TN Direction de la Pharmacie et du Mรฉdicament Identifier(s): 6533061H, 6533062

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.